Related Experiment Video
Updated: Sep 19, 2025

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
[Post-radiation choroidal melanoma pathomorphosis assessment in clinical practice]
I E Panova1,2,3, E M Svistunova1, E V Samkovich1
1S. Fyodorov Eye Microsurgery Federal State Institution, the St. Petersburg Branch, St. Petersburg, Russia.
Secondary enucleation after choroidal melanoma (CM) treatments revealed persistent viable tumor cells and mitotic activity. This indicates a high risk of continued tumor growth and metastasis, even after organ-preserving therapies.
Area of Science:
- Ophthalmology
- Oncology
- Pathology
Context:
- Choroidal melanoma (CM) is a rare intraocular malignancy.
- Organ-preserving treatments aim to save the eye while managing CM.
- Secondary enucleation is sometimes necessary after initial treatment.
Purpose:
- To investigate the pathomorphological changes in eyes requiring secondary enucleation post-CM treatment.
- To assess the effectiveness of various organ-preserving therapies (brachytherapy, proton therapy, Gamma Knife) by examining enucleated eyes.
Summary:
- This study analyzed 22 enucleated eyes with CM treated with organ-preserving methods.
- Common findings included scleral invasion, Bruch's membrane rupture, and lymphocytic infiltration.
- Therapeutic effects showed significant TRG4 and TRG3 grades, with low vascular invasion but persistent viable tumor cells and mitotic activity (average 1.6±1.5/mm²).
Impact:
- Findings highlight that residual viable tumor cells and mitotic activity post-treatment signify incomplete tumor control.
- This underscores a significant risk for tumor recurrence and metastasis, irrespective of the organ-preserving strategy used.
- The study informs prognostic assessments and treatment strategies for choroidal melanoma.
More Related Videos
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023